Akoya Biosciences (NASDAQ:AKYA – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Akoya Biosciences to related businesses based on the strength of its valuation, dividends, analyst recommendations, institutional ownership, profitability, earnings and risk. Profitability This table compares Akoya Biosciences […]
Akoya Biosciences (NASDAQ:AKYA – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it compare to its peers? We will compare Akoya Biosciences to related businesses based on the strength of its analyst recommendations, profitability, earnings, risk, dividends, valuation and institutional ownership. Earnings and Valuation This table compares […]
Akoya Biosciences (NASDAQ:AKYA – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Akoya Biosciences to related companies based on the strength of its dividends, analyst recommendations, institutional ownership, profitability, earnings, valuation and risk. Earnings and Valuation This table compares […]
Akoya Biosciences (NASDAQ:AKYA – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Akoya Biosciences to similar companies based on the strength of its institutional ownership, profitability, earnings, risk, analyst recommendations, valuation and dividends. Profitability This table compares […]
Akoya Biosciences (NASDAQ:AKYA – Get Rating) had its price target reduced by Morgan Stanley from $20.00 to $19.00 in a report issued on Tuesday, MarketBeat.com reports. Morgan Stanley currently has an overweight rating on the stock. Separately, Zacks Investment Research upgraded Akoya Biosciences from a sell rating to a hold rating in a research report […]